Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

DFS Furniture lifts full-year profit outlook, shares surge

(Sharecast News) - DFS Furniture surged on Thursday as it lifted its full-year profit outlook following an improved profit performance in the first half. In the 26 weeks to 29 December 2024, underlying pre-tax profit rose to £17m from £8.7m.

Gross sales ticked up 1.4% to £675.6m and order intake grew 10.1% in a "subdued" market, having fallen 1.1% in the same period a year earlier, with both the DFS and Sofology brands gaining market share.

Revenue dipped 0.1% to £504.5m due to an investment in the company's interest free credit offer to maximise cash gross margins "in a challenging consumer landscape".

DFS said trading through the first 10 weeks of the second half has remained strong, with order intake increasing from the 10% growth achieved in the first half, with its year-to-date order intake now up 11%.

As a result of the continued strong trading, good cost control and assuming no further supply chain disruption, the company expects to outperform consensus expectations and deliver underlying pre-tax profit of between £25m and £29m.

Chief executive Tim Stacey said: "Our improved profit performance in the first half is testament to the strength of our customer proposition, the dedication of our colleagues and our collective focus on operational excellence, evidenced through increased market shares and customer satisfaction scores.

"We are on track to deliver full year profit performance ahead of market expectations and our confidence in the group's capabilities and future potential has never been higher. Given our strong market position and relentless focus on executing our strategy, we are confident that we will achieve our £1.4bn full year revenue and 8% profit before tax targets in the medium term and deliver strong returns for our shareholders."

At 0915 GMT, the shares were up 11.3% at 146p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.